Beta Bionics, Inc.
BBNX
$17.04
$0.331.98%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 78.02M | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 78.02M | -- | -- | -- | |
| Cost of Revenue | 35.95M | -- | -- | -- | |
| Gross Profit | 42.08M | -- | -- | -- | |
| SG&A Expenses | 73.79M | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 140.55M | -- | -- | -- | |
| Operating Income | -62.53M | -- | -- | -- | |
| Income Before Tax | -73.37M | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -73.37 | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -73.37M | -- | -- | -- | |
| EBIT | -62.53M | -- | -- | -- | |
| EBITDA | -61.34M | -- | -- | -- | |
| EPS Basic | -5.59 | -- | -- | -- | |
| Normalized Basic EPS | -3.50 | -- | -- | -- | |
| EPS Diluted | -5.59 | -- | -- | -- | |
| Normalized Diluted EPS | -3.50 | -- | -- | -- | |
| Average Basic Shares Outstanding | 87.04M | -- | -- | -- | |
| Average Diluted Shares Outstanding | 87.04M | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |